Valby,
NOTICE OF EXTRAORDINARY GENERAL MEETING
Notice is hereby given for an extraordinary general meeting of
Wednesday,
The extraordinary general meeting will be held at the offices of the Company at:
Agenda
The agenda of the meeting is as follows:
1. Proposals by the Board of Directors:
1. Proposal from the Board of Directors to split the Company's existing shares into A-shares and B-shares and amend the articles of association, including to implement certain pre-emption rights.
2. Proposal from the Board of Directors to amend the authorization to the Board of Directors to increase the share capital of the Company.
3. Proposal from the Board of Directors to amend the Remuneration Policy for the Board of Directors and Executive Management.
4. Proposal from the Board of Directors to authorize each of the Chairman of the meeting and
ADDITIONAL INFORMATION- EXCHANGE OFFER BY THE LUNDBECK FOUNDATION
As previously announced, the
PRACTICAL INFORMATION
If you have functional impairments which make passage from the entrance to the Auditorium difficult, you may request assistance from the staff upon arrival at the reception.
Registration, admission cards and notice of attendance (requirement for attending the extraordinary general meeting)
In accordance with Article 10.1 of the Articles of Association, admission cards will be provided to shareholders entitled to vote at the extraordinary general meeting. Anyone who is registered as a shareholder in the register of shareholders on the date of registration, 1.
Admission cards for the extraordinary general meeting can be obtained up to and including
Admission cards will be sent out electronically via email to the email address specified in the investor portal upon registration. The admission card must be presented at the extraordinary general meeting either electronically on a smartphone/tablet or in print.
Shareholders who have ordered admission cards without specifying their email address can pick up the admission card at the entrance of the extraordinary general meeting upon presentation of valid ID.
Voting cards will be handed out at the entrance of the extraordinary general meeting.
Contact:
Investors
Vice President
Investor Relations
E: PALO@lundbeck.com
T: +45 30 83 24 26
Media
Media Relations Lead, Corp. Communication
E: THMR@lundbeck.com
T: +45 30 83 30 24
About
Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best. We are committed to fighting stigma and discrimination against people living with brain diseases and advocating for broader social acceptance of people with brain health conditions. Our research programs tackle some of the most complex challenges in neuroscience, and our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options.
(C) 2022 Electronic News Publishing, source